POL HCQ ethics
(Unterschied zwischen Versionen)
(Die Seite wurde neu angelegt: „{{tp|p=32279469|t=2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.|pdf=|usr=007}} {{tp|p=32238355|t=2020. Covid-19: US g…“) |
K |
||
| Zeile 1: | Zeile 1: | ||
{{tp|p=32279469|t=2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.|pdf=|usr=007}} | {{tp|p=32279469|t=2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.|pdf=|usr=007}} | ||
{{tp|p=32238355|t=2020. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.|pdf=|usr=007}} | {{tp|p=32238355|t=2020. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.|pdf=|usr=007}} | ||
| + | {{tp|p=32294807|t=2020. Hydroxychloroquine use during the COVID-19 pandemic 2020.|pdf=|usr=007}} | ||
| + | {{tp|p=32389025|t=2020. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.|pdf=|usr=008}} | ||
Version vom 5. Dezember 2020, 15:11 Uhr
32279469 2020. Off-label prescribing in the midst of a pandemic: The case of hydroxychloroquine.
32238355 2020. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence.
32294807 2020. Hydroxychloroquine use during the COVID-19 pandemic 2020.
32389025 2020. Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.
